SCHEMBL20048746

SCHEMBL20048746

CSc1cccc(S(=O)(=O)Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.51
GAA P10253 1/20 0.51
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 6/20 0.40
MEN1 O00255 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
TSHR P16473 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
ANXA2 P07355 1/20 0.40
S100A10 P60903 1/20 0.40
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30306605 1.00 HPGD (0.51) HPGDGAAALDH1A1HSD17B10TDP1
SCHEMBL10078922 0.82 HPGD (0.53) HPGDGAAALDH1A1HSD17B10L3MBTL1
SCHEMBL7136145 0.80 CA2 (0.61) HPGDGAAL3MBTL1ANXA2S100A10
SCHEMBL26610860 0.80 TSHR (0.52) HPGDGAAALDH1A1HSD17B10TDP1
SCHEMBL7755598 0.78 ALDH1A1 (0.45) HPGDGAAALDH1A1HSD17B10TDP1
Hydrochloric Acid SCHEMBL28261327 0.78 TSHR (0.50) HPGDGAAALDH1A1HSD17B10TDP1
SCHEMBL56599 0.78 ALDH1A1 (0.65) HPGDGAAALDH1A1HSD17B10TDP1
SCHEMBL3362244 0.77 HPGD (0.57) HPGDGAAALDH1A1L3MBTL1KMT2A
SCHEMBL22812725 0.77 RAB9A (0.56) HPGDGAAALDH1A1L3MBTL1KMT2A
SCHEMBL13913369 0.77 ALDH1A1 (0.39) HPGDGAAALDH1A1HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11802110-B2 2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase Oxford Drug Design Limited (GB) 2023-10-31 US disclosed
CN-110049970-B 2-amino-N- (arylsulfinyl) -acetamide compounds as inhibitors of bacterial aminoacyl-TRNA synthase 牛津药物设计有限公司 2023-04-11 CN disclosed
CN-108863959-B P2X4 receptor antagonists 日本化学药品株式会社 2021-11-30 CN disclosed
CN-111333588-A P2X4 receptor antagonists 日本化学药品株式会社 2020-06-26 CN disclosed
CN-104066724-B P2X4 receptor antagonists 日本化学药品株式会社 2020-04-17 CN disclosed
US-20200039929-A1 2-AMINO-N-(ARYLSULFINYL)-ACETAMIDE COMPOUNDS AS INHIBITORS OF BACTERIAL AMINOACYL-TRNA SYNTHETASE INHIBOX LIMITED (GB) 2020-02-06 US disclosed
WO-2018065611-A1 2-AMINO-N-(ARYLSULFINYL)-ACETAMIDE COMPOUNDS AS INHIBITORS OF BACTERIAL AMINOACYL-TRNA SYNTHETASE Oxford Drug Design Limited (GB) 2018-04-12 WO disclosed
CN-104066724-A P2X4 receptor antagonists NIPPON CHEMIPHAR CO 2014-09-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11802110-B2 2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase AARS1, NSUN3, GARS1 HPGD 3784/4885GAA 464/4885ALDH1A1 1814/4885
US-20200039929-A1 2-AMINO-N-(ARYLSULFINYL)-ACETAMIDE COMPOUNDS AS INHIBITORS OF BACTERIAL AMINOACYL-TRNA SYNTHETASE AARS1, NSUN3, GARS1 HPGD 3784/4885GAA 464/4885ALDH1A1 1814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.